Daniel joined SEP in 2021 and works principally on deal origination, execution and support, and the assessment of new, growth stage, technology investments.

He was a key member of the deal teams which led SEP’s investments into accounts payable automation software company Springtime; and drug discovery and design software vendor Cresset.

Daniel joined SEP from global private markets investment firm StepStone Group, where he was a member of the EMEA Private Equity team. Prior to that, Daniel began his career in Investment Banking at Goldman Sachs in London, where he worked on a range of transactions for high growth, technology-enabled, corporate clients.

He is a graduate of the University of Bath and holds a BEng (Hons) in Chemical Engineering.

‍